Apollo Hospitals Enterprise Limited Annual Report FY2026
Apollo Hospitals Enterprise Limited Annual Report FY2026
Quality Scores
Latest Quarterly Earnings Summary
Loading latest quarter…
Unlock the full 22-section intelligence dossier for Apollo Hospitals Enterprise Limited
All 21 scores, fair value models, forensic red-flag audit, management promise tracker, AI chat and PDF.
Executive Intelligence Brief
- Apollo Hospitals (AHEL) is Asia's foremost integrated healthcare provider, operating a robust 10,200-bed network across 73 hospitals.
- The firm has successfully transitioned from a pure-play hospital chain to an omnichannel health powerhouse through Apollo 24/7 and its massive pharmacy network.
- Over the last decade, sales have grown at a 15% CAGR, transitioning from capital-intensive hospital builds to high-utilization and digital-led growth.
- Apollo has evolved from a single hospital in 1983 to a massive integrated healthcare provider spanning 73 hospitals and over 5,000 pharmacy stores.
- The last decade has seen a critical shift from a purely brick-and-mortar hospital chain to an omni-channel healthcare ecosystem including diagnostics, primary care, and the 'Apollo 24/7' digital platform.
- Reddy, management has demonstrated high transparency and strategic clarity over four decades.
- The transition to the next generation of leadership among the four daughters has been seamless and well-received by the market.
- The financial profile is characterized by steady 15% revenue growth and an impressive 78% PAT CAGR over the last 5 years, albeit from a lower base in FY18-FY21.
- Operating margins have stabilized in the 13-15% range as newer hospitals reach maturity and occupancy levels optimize.
Full chapters continue in the complete report.
- Multi-model fair value computed
- Fair value range & margin of safety
- Beneish M-Score: Safe zone
- Altman Z-Score: Safe zone
- 10 structural traps scanned
- 3 red flags documented
- 6 auditor checks run
- 10 risks ranked by severity
- 3 management promises tracked
- 10 growth drivers identified
16 more proprietary scores
Major Opportunities
- Market leader in Indian private healthcare with 10k+ beds
- Diversified revenue across hospitals, pharmacy, and digital
- Strong 5-year Profit CAGR of 78%
- Consistent improvement in OPM from 10% to 15%
- Highly professional management with long-term vision
Major Risks
- Extremely high valuation (Price-to-Book ~13x)
- Declining promoter holding over the last 10 years
- High capital intensity requiring constant debt/equity updates
- Regulatory risks regarding medical pricing and compliance
- Significant increase in debt in FY25-FY26
Included in the Full Report
This brief shows only the highlights. Unlock the complete analysis:
About This Annual Report
The Apollo Hospitals Enterprise Limited FY2026 Annual Report is the company's flagship annual disclosure, filed with NSE / BSE. It covers the full-year business review, management discussion & analysis (MD&A), audited financial statements, director's report, corporate governance report, auditor's report, risk factors, capital allocation, subsidiaries, related-party transactions and ESG initiatives. This page consolidates the official PDF and an AI-generated summary so investors can quickly grasp what changed vs. prior years — sales growth, margin trend, cash flow quality, capex, dividends and management outlook — without having to read the entire filing.
Why Use AI?
- Summarises hundreds of pages into a focused executive briefing
- Identifies year-on-year key changes automatically
- Extracts management commentary and tone
- Highlights top risks and opportunities
- Compares business evolution vs. earlier years
- Answers your questions in plain English via Ask AI
Frequently Asked Questions
Related Research
AI Top Insights — Premium
Unlock deeper AI Top Insights, advanced comparisons, downloadable reports and premium features.